المؤلفون: Carmona Rocha, Elena, Rusiñol, Lluís, Puig Sanz, Lluís, Universitat Autònoma de Barcelona. Departament de Medicina

مصطلحات موضوعية: Psoriasis, Oral therapies, Topical therapies, Biologics, Jak inhibitors, PDE4 inhibitors, Systemic treatment, IL-17 inhibitors, IL-23 inhibitors, Tapinarof, Roflumilast

وصف الملف: application/pdf

Relation: Pharmaceutics; Vol. 16, Num. 2 (february 2024); https://ddd.uab.cat/record/290359; urn:10.3390/pharmaceutics16020239; urn:oai:ddd.uab.cat:290359; urn:pmcid:PMC10892104; urn:pmc-uid:10892104; urn:pmid:38399292; urn:oai:pubmedcentral.nih.gov:10892104; urn:oai:egreta.uab.cat:publications/7dfd1cb7-0235-4bd3-9fc8-dba4bf18f4dc

الاتاحة: https://ddd.uab.cat/record/290359

المؤلفون: Elena Carmona-Rocha, Lluís Rusiñol, Lluís Puig

المصدر: Pharmaceutics, Vol 16, Iss 2, p 239 (2024)

مصطلحات موضوعية: psoriasis, oral therapies, topical therapies, biologics, Jak inhibitors, PDE4 inhibitors, Pharmacy and materia medica, RS1-441

Relation: https://www.mdpi.com/1999-4923/16/2/239; https://doaj.org/toc/1999-4923; https://doaj.org/article/44e4c44a767346fe95a014887f67db90

الاتاحة: https://doi.org/10.3390/pharmaceutics16020239
https://doaj.org/article/44e4c44a767346fe95a014887f67db90

المؤلفون: Claudia Herrera-deGuise, Xavier Serra-Ruiz, Ernesto Lastiri, Natalia Borruel

المصدر: Frontiers in Medicine, Vol 10 (2023)

مصطلحات موضوعية: inflammatory bowel diseases, JAK inhibitors, treatment, oral therapies, small molecules, Medicine (General), R5-920

وصف الملف: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fmed.2023.1089099/full; https://doaj.org/toc/2296-858X

URL الوصول: https://doaj.org/article/5c2b5cb96774495faebe188e8bd35e71

المؤلفون: Brima Musa Younis, Ahmed Mudawi Musa, Séverine Monnerat, Mohammed Abdelrahim Saeed, Eltahir Awad Gasim Khalil, Anas Elbashir Ahmed, Mujahid Ahmed Ali, Ali Noureldin, Gina Muthoni Ouattara, Godfrey M. Nyakaya, Samuel Teshome, Truphosa Omollo, Michael Ochieng, Thaddaeus Egondi, Mildred Mmbone, Wan-Yu Chu, Thomas P. C. Dorlo, Eduard E. Zijlstra, Monique Wasunna, Jorge Alvar, Fabiana Alves

مصطلحات موضوعية: Medicine, Pharmacology, Biotechnology, Cancer, Infectious Diseases, Virology, Computational Biology, liposomal amphotericin b, future vl elimination, either daily intra, azar dermal leishmaniasis, 2 %, 3 &# 8211, 2 &# 8211, 0 %, 110 patients completed, 0 &# 8211, actual treatment received, grade 3 pkdl, least one dose, plus oral miltefosine, mf &# 8211, additional pkdl treatment, randomized patients receiving, currently recommended 60, 6 %) patients, 12 years old, +treatment%22">xlink "> treatment, safe oral therapies

Time: 95

Relation: https://figshare.com/articles/journal_contribution/CONSORT_2010_checklist_of_information_to_include_when_reporting_a_randomised_trial_/24601630

الاتاحة: https://doi.org/10.1371/journal.pntd.0011780.s003
https://figshare.com/articles/journal_contribution/CONSORT_2010_checklist_of_information_to_include_when_reporting_a_randomised_trial_/24601630

المؤلفون: Brima Musa Younis, Ahmed Mudawi Musa, Séverine Monnerat, Mohammed Abdelrahim Saeed, Eltahir Awad Gasim Khalil, Anas Elbashir Ahmed, Mujahid Ahmed Ali, Ali Noureldin, Gina Muthoni Ouattara, Godfrey M. Nyakaya, Samuel Teshome, Truphosa Omollo, Michael Ochieng, Thaddaeus Egondi, Mildred Mmbone, Wan-Yu Chu, Thomas P. C. Dorlo, Eduard E. Zijlstra, Monique Wasunna, Jorge Alvar, Fabiana Alves

مصطلحات موضوعية: Medicine, Pharmacology, Biotechnology, Cancer, Infectious Diseases, Virology, Computational Biology, liposomal amphotericin b, future vl elimination, either daily intra, azar dermal leishmaniasis, 2 %, 3 &# 8211, 2 &# 8211, 0 %, 110 patients completed, 0 &# 8211, actual treatment received, grade 3 pkdl, least one dose, plus oral miltefosine, mf &# 8211, additional pkdl treatment, randomized patients receiving, currently recommended 60, 6 %) patients, 12 years old, +treatment%22">xlink "> treatment, safe oral therapies

Time: 95

Relation: https://figshare.com/articles/journal_contribution/PKDL_Sudan_Study_Synopsis_/24601627

الاتاحة: https://doi.org/10.1371/journal.pntd.0011780.s002
https://figshare.com/articles/journal_contribution/PKDL_Sudan_Study_Synopsis_/24601627

المؤلفون: Brima Musa Younis, Ahmed Mudawi Musa, Séverine Monnerat, Mohammed Abdelrahim Saeed, Eltahir Awad Gasim Khalil, Anas Elbashir Ahmed, Mujahid Ahmed Ali, Ali Noureldin, Gina Muthoni Ouattara, Godfrey M. Nyakaya, Samuel Teshome, Truphosa Omollo, Michael Ochieng, Thaddaeus Egondi, Mildred Mmbone, Wan-Yu Chu, Thomas P. C. Dorlo, Eduard E. Zijlstra, Monique Wasunna, Jorge Alvar, Fabiana Alves

مصطلحات موضوعية: Medicine, Pharmacology, Biotechnology, Cancer, Infectious Diseases, Virology, Computational Biology, liposomal amphotericin b, future vl elimination, either daily intra, azar dermal leishmaniasis, 2 %, 3 &# 8211, 2 &# 8211, 0 %, 110 patients completed, 0 &# 8211, actual treatment received, grade 3 pkdl, least one dose, plus oral miltefosine, mf &# 8211, additional pkdl treatment, randomized patients receiving, currently recommended 60, 6 %) patients, 12 years old, +treatment%22">xlink "> treatment, safe oral therapies

Time: 95

Relation: https://figshare.com/articles/journal_contribution/Supplementary_material_/24601538

الاتاحة: https://doi.org/10.1371/journal.pntd.0011780.s001
https://figshare.com/articles/journal_contribution/Supplementary_material_/24601538

المؤلفون: Mario Nuvolone, Maria Girelli, Giampaolo Merlini

المصدر: International Journal of Molecular Sciences; Volume 23; Issue 24; Pages: 16145

مصطلحات موضوعية: amyloidosis, cardiac amyloidosis, amyloid cardiomyopathy, transthyretin, ATTR amyloidosis, emerging therapies, oral therapies

جغرافية الموضوع: agris

وصف الملف: application/pdf

Relation: Molecular Biology; https://dx.doi.org/10.3390/ijms232416145

الاتاحة: https://doi.org/10.3390/ijms232416145

المؤلفون: Alessandra Schiapaccassa, Priscila A. Maranhão, Maria das Graças Coelho de Souza, Diogo G. Panazzolo, José Firmino Nogueira Neto, Eliete Bouskela, Luiz Guilherme Kraemer-Aguiar

المصدر: Diabetology & Metabolic Syndrome, Vol 11, Iss 1, Pp 1-9 (2019)

مصطلحات موضوعية: Diabetes, Obesity, Oral therapies, Endothelium, Nutritional diseases. Deficiency diseases, RC620-627

وصف الملف: electronic resource

Relation: http://link.springer.com/article/10.1186/s13098-019-0466-2; https://doaj.org/toc/1758-5996

URL الوصول: https://doaj.org/article/02ca5b41ec794f7d99a8025235a628cb

المؤلفون: Muntoni E., Anfossi L., Milla P., Marini E., Ferraris C., Capucchio M. T., Colombino E., Segale L., Porta M., Battaglia L.

المساهمون: Muntoni E., Anfossi L., Milla P., Marini E., Ferraris C., Capucchio M.T., Colombino E., Segale L., Porta M., Battaglia L.

مصطلحات موضوعية: Insulin therapy, Nanostructured lipid carrier, Oral therapies

Relation: info:eu-repo/semantics/altIdentifier/pmid/33131992; info:eu-repo/semantics/altIdentifier/wos/WOS:000618872600040; volume:31; firstpage:691; lastpage:698; numberofpages:8; journal:NMCD. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES; http://hdl.handle.net/2318/1768846; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85094571120

الاتاحة: http://hdl.handle.net/2318/1768846
https://doi.org/10.1016/j.numecd.2020.09.020

المؤلفون: Teresa Spadea (6257027), Roberta Onorati (346419), Francesca Baratta (3834013), Irene Pignata (11401826), Marco Parente (6257021), Lavinia Pannacci (11401829), Domenica Ancona (8296281), Paola Ribecco (11401832), Giuseppe Costa (327497), Roberto Gnavi (327498), Paola Brusa (6257012)

مصطلحات موضوعية: Medicine, Biotechnology, Cancer, Science Policy, Mental Health, Infectious Diseases, Virology, usual operating setting, plan interventions addressed, different italian areas, 9 %) returned, 11 &# 8211, recommended clinical examinations, recently diagnosed patients, less educated patients, +overall%22">xlink "> overall, type 2 diabetes, prescribed pharmacological therapies, pharmacists &# 8217, italy , higher among younger, found low rates, examinations among patients, regular clinical follow, community pharmacy programme, adherent received counselling, clinical examinations, %22">xlink ">, pharmacological therapy, oral therapies

Relation: https://figshare.com/articles/journal_contribution/Study_flow_chart_/16579190

الاتاحة: https://doi.org/10.1371/journal.pone.0256478.s003

المؤلفون: Teresa Spadea (6257027), Roberta Onorati (346419), Francesca Baratta (3834013), Irene Pignata (11401826), Marco Parente (6257021), Lavinia Pannacci (11401829), Domenica Ancona (8296281), Paola Ribecco (11401832), Giuseppe Costa (327497), Roberto Gnavi (327498), Paola Brusa (6257012)

مصطلحات موضوعية: Medicine, Biotechnology, Cancer, Science Policy, Mental Health, Infectious Diseases, Virology, usual operating setting, plan interventions addressed, different italian areas, 9 %) returned, 11 &# 8211, recommended clinical examinations, recently diagnosed patients, less educated patients, +overall%22">xlink "> overall, type 2 diabetes, prescribed pharmacological therapies, pharmacists &# 8217, italy , higher among younger, found low rates, examinations among patients, regular clinical follow, community pharmacy programme, adherent received counselling, clinical examinations, %22">xlink ">, pharmacological therapy, oral therapies

Relation: https://figshare.com/articles/journal_contribution/Patient_questionnaires_/16579184

الاتاحة: https://doi.org/10.1371/journal.pone.0256478.s001

المؤلفون: Teresa Spadea (6257027), Roberta Onorati (346419), Francesca Baratta (3834013), Irene Pignata (11401826), Marco Parente (6257021), Lavinia Pannacci (11401829), Domenica Ancona (8296281), Paola Ribecco (11401832), Giuseppe Costa (327497), Roberto Gnavi (327498), Paola Brusa (6257012)

مصطلحات موضوعية: Medicine, Biotechnology, Cancer, Science Policy, Mental Health, Infectious Diseases, Virology, usual operating setting, plan interventions addressed, different italian areas, 9 %) returned, 11 &# 8211, recommended clinical examinations, recently diagnosed patients, less educated patients, +overall%22">xlink "> overall, type 2 diabetes, prescribed pharmacological therapies, pharmacists &# 8217, italy , higher among younger, found low rates, examinations among patients, regular clinical follow, community pharmacy programme, adherent received counselling, clinical examinations, %22">xlink ">, pharmacological therapy, oral therapies

Relation: https://figshare.com/articles/journal_contribution/Pharmacists_satisfaction_questionnaire_/16579187

الاتاحة: https://doi.org/10.1371/journal.pone.0256478.s002

المؤلفون: K. Raja Reddy (2325832), Jonathan Parkinson (7220564), Mojgan Sabet (35195), Ziad Tarazi (8658438), Serge H. Boyer (2245465), Olga Lomovskaya (2983224), David C. Griffith (8658426), Scott J. Hecker (2245453), Michael N. Dudley (5745498)

مصطلحات موضوعية: Biochemistry, Medicine, Microbiology, Pharmacology, Infectious Diseases, Biological Sciences not elsewhere classified, Chemical Sciences not elsewhere classified, pharmacokinetics across species, optimal properties across, negative bacterial infections, directed toward identifying, orally bioavailable prodrug, key properties investigated, effective oral therapies, na , oral prodrug, key attributes, treat gram, seventeen prodrugs, active form

Relation: https://figshare.com/articles/journal_contribution/Selection_of_QPX7831_an_Orally_Bioavailable_Prodrug_of_Boronic_Acid_Lactamase_Inhibitor_QPX7728/17075897

الاتاحة: https://doi.org/10.1021/acs.jmedchem.1c01722.s001

المؤلفون: Khoa Nguyen, Nazanin Ehsani-Chimeh, Nicole Salame, April W. Armstrong

المصدر: Journal of Dermatological Treatment, Vol 32, Iss 4, Pp 440-445 (2021)

مصطلحات موضوعية: annual wages, wages, work hours, psoriasis, biologics, oral therapies, absenteeism, presenteeism, Dermatology, RL1-803

Relation: http://dx.doi.org/10.1080/09546634.2019.1666966; https://doaj.org/toc/0954-6634; https://doaj.org/toc/1471-1753; https://doaj.org/article/55bac7b9069648759a7c778a5ff33ab4

الاتاحة: https://doi.org/10.1080/09546634.2019.1666966
https://doaj.org/article/55bac7b9069648759a7c778a5ff33ab4

المؤلفون: Brima Musa Younis, Ahmed Mudawi Musa, Séverine Monnerat, Mohammed Abdelrahim Saeed, Eltahir Awad Gasim Khalil, Anas Elbashir Ahmed, Mujahid Ahmed Ali, Ali Noureldin, Gina Muthoni Ouattara, Godfrey M. Nyakaya, Samuel Teshome, Truphosa Omollo, Michael Ochieng, Thaddaeus Egondi, Mildred Mmbone, Wan-Yu Chu, Thomas P. C. Dorlo, Eduard E. Zijlstra, Monique Wasunna, Jorge Alvar, Fabiana Alves

مصطلحات موضوعية: Medicine, Pharmacology, Biotechnology, Cancer, Infectious Diseases, Virology, Computational Biology, liposomal amphotericin b, future vl elimination, either daily intra, azar dermal leishmaniasis, 2 %, 3 &# 8211, 2 &# 8211, 0 %, 110 patients completed, 0 &# 8211, actual treatment received, grade 3 pkdl, least one dose, plus oral miltefosine, mf &# 8211, additional pkdl treatment, randomized patients receiving, currently recommended 60, 6 %) patients, 12 years old, +treatment%22">xlink "> treatment, safe oral therapies

Time: 95

Relation: https://figshare.com/articles/figure/Fig_1_-/24601636

الاتاحة: https://doi.org/10.1371/journal.pntd.0011780.g001
https://figshare.com/articles/figure/Fig_1_-/24601636

المؤلفون: Brima Musa Younis, Ahmed Mudawi Musa, Séverine Monnerat, Mohammed Abdelrahim Saeed, Eltahir Awad Gasim Khalil, Anas Elbashir Ahmed, Mujahid Ahmed Ali, Ali Noureldin, Gina Muthoni Ouattara, Godfrey M. Nyakaya, Samuel Teshome, Truphosa Omollo, Michael Ochieng, Thaddaeus Egondi, Mildred Mmbone, Wan-Yu Chu, Thomas P. C. Dorlo, Eduard E. Zijlstra, Monique Wasunna, Jorge Alvar, Fabiana Alves

مصطلحات موضوعية: Medicine, Pharmacology, Biotechnology, Cancer, Infectious Diseases, Virology, Computational Biology, liposomal amphotericin b, future vl elimination, either daily intra, azar dermal leishmaniasis, 2 %, 3 &# 8211, 2 &# 8211, 0 %, 110 patients completed, 0 &# 8211, actual treatment received, grade 3 pkdl, least one dose, plus oral miltefosine, mf &# 8211, additional pkdl treatment, randomized patients receiving, currently recommended 60, 6 %) patients, 12 years old, +treatment%22">xlink "> treatment, safe oral therapies

Time: 95

Relation: https://figshare.com/articles/figure/PKDL_lesion_distribution_grade_over_time_by_treatment_arm_mITT_set_/24601642

الاتاحة: https://doi.org/10.1371/journal.pntd.0011780.g003
https://figshare.com/articles/figure/PKDL_lesion_distribution_grade_over_time_by_treatment_arm_mITT_set_/24601642

المؤلفون: Brima Musa Younis, Ahmed Mudawi Musa, Séverine Monnerat, Mohammed Abdelrahim Saeed, Eltahir Awad Gasim Khalil, Anas Elbashir Ahmed, Mujahid Ahmed Ali, Ali Noureldin, Gina Muthoni Ouattara, Godfrey M. Nyakaya, Samuel Teshome, Truphosa Omollo, Michael Ochieng, Thaddaeus Egondi, Mildred Mmbone, Wan-Yu Chu, Thomas P. C. Dorlo, Eduard E. Zijlstra, Monique Wasunna, Jorge Alvar, Fabiana Alves

مصطلحات موضوعية: Medicine, Pharmacology, Biotechnology, Cancer, Infectious Diseases, Virology, Computational Biology, liposomal amphotericin b, future vl elimination, either daily intra, azar dermal leishmaniasis, 2 %, 3 &# 8211, 2 &# 8211, 0 %, 110 patients completed, 0 &# 8211, actual treatment received, grade 3 pkdl, least one dose, plus oral miltefosine, mf &# 8211, additional pkdl treatment, randomized patients receiving, currently recommended 60, 6 %) patients, 12 years old, +treatment%22">xlink "> treatment, safe oral therapies

Time: 95

Relation: https://figshare.com/articles/dataset/Primary_efficacy_outcome_of_definitive_cure_at_12_months_by_treatment_arm_mITT_and_PP_sets_/24601651

الاتاحة: https://doi.org/10.1371/journal.pntd.0011780.t002
https://figshare.com/articles/dataset/Primary_efficacy_outcome_of_definitive_cure_at_12_months_by_treatment_arm_mITT_and_PP_sets_/24601651

المؤلفون: Brima Musa Younis, Ahmed Mudawi Musa, Séverine Monnerat, Mohammed Abdelrahim Saeed, Eltahir Awad Gasim Khalil, Anas Elbashir Ahmed, Mujahid Ahmed Ali, Ali Noureldin, Gina Muthoni Ouattara, Godfrey M. Nyakaya, Samuel Teshome, Truphosa Omollo, Michael Ochieng, Thaddaeus Egondi, Mildred Mmbone, Wan-Yu Chu, Thomas P. C. Dorlo, Eduard E. Zijlstra, Monique Wasunna, Jorge Alvar, Fabiana Alves

مصطلحات موضوعية: Medicine, Pharmacology, Biotechnology, Cancer, Infectious Diseases, Virology, Computational Biology, liposomal amphotericin b, future vl elimination, either daily intra, azar dermal leishmaniasis, 2 %, 3 &# 8211, 2 &# 8211, 0 %, 110 patients completed, 0 &# 8211, actual treatment received, grade 3 pkdl, least one dose, plus oral miltefosine, mf &# 8211, additional pkdl treatment, randomized patients receiving, currently recommended 60, 6 %) patients, 12 years old, +treatment%22">xlink "> treatment, safe oral therapies

Time: 95

Relation: https://figshare.com/articles/figure/Median_plasma_and_skin_concentrations_of_miltefosine_on_days_28_and_42_of_paromomycin_on_day_14_and_liposomal_amphotericin_B_on_day_7_/24601645

الاتاحة: https://doi.org/10.1371/journal.pntd.0011780.g004
https://figshare.com/articles/figure/Median_plasma_and_skin_concentrations_of_miltefosine_on_days_28_and_42_of_paromomycin_on_day_14_and_liposomal_amphotericin_B_on_day_7_/24601645

المؤلفون: Brima Musa Younis, Ahmed Mudawi Musa, Séverine Monnerat, Mohammed Abdelrahim Saeed, Eltahir Awad Gasim Khalil, Anas Elbashir Ahmed, Mujahid Ahmed Ali, Ali Noureldin, Gina Muthoni Ouattara, Godfrey M. Nyakaya, Samuel Teshome, Truphosa Omollo, Michael Ochieng, Thaddaeus Egondi, Mildred Mmbone, Wan-Yu Chu, Thomas P. C. Dorlo, Eduard E. Zijlstra, Monique Wasunna, Jorge Alvar, Fabiana Alves

مصطلحات موضوعية: Medicine, Pharmacology, Biotechnology, Cancer, Infectious Diseases, Virology, Computational Biology, liposomal amphotericin b, future vl elimination, either daily intra, azar dermal leishmaniasis, 2 %, 3 &# 8211, 2 &# 8211, 0 %, 110 patients completed, 0 &# 8211, actual treatment received, grade 3 pkdl, least one dose, plus oral miltefosine, mf &# 8211, additional pkdl treatment, randomized patients receiving, currently recommended 60, 6 %) patients, 12 years old, +treatment%22">xlink "> treatment, safe oral therapies

Time: 95

Relation: https://figshare.com/articles/figure/Kaplan-Meier_curve_of_time_to_complete_cure_by_treatment_arm_and_overall_mITT_set_/24601639

الاتاحة: https://doi.org/10.1371/journal.pntd.0011780.g002
https://figshare.com/articles/figure/Kaplan-Meier_curve_of_time_to_complete_cure_by_treatment_arm_and_overall_mITT_set_/24601639

المؤلفون: Brima Musa Younis, Ahmed Mudawi Musa, Séverine Monnerat, Mohammed Abdelrahim Saeed, Eltahir Awad Gasim Khalil, Anas Elbashir Ahmed, Mujahid Ahmed Ali, Ali Noureldin, Gina Muthoni Ouattara, Godfrey M. Nyakaya, Samuel Teshome, Truphosa Omollo, Michael Ochieng, Thaddaeus Egondi, Mildred Mmbone, Wan-Yu Chu, Thomas P. C. Dorlo, Eduard E. Zijlstra, Monique Wasunna, Jorge Alvar, Fabiana Alves

مصطلحات موضوعية: Medicine, Pharmacology, Biotechnology, Cancer, Infectious Diseases, Virology, Computational Biology, liposomal amphotericin b, future vl elimination, either daily intra, azar dermal leishmaniasis, 2 %, 3 &# 8211, 2 &# 8211, 0 %, 110 patients completed, 0 &# 8211, actual treatment received, grade 3 pkdl, least one dose, plus oral miltefosine, mf &# 8211, additional pkdl treatment, randomized patients receiving, currently recommended 60, 6 %) patients, 12 years old, +treatment%22">xlink "> treatment, safe oral therapies

Time: 95

Relation: https://figshare.com/articles/dataset/Baseline_characteristics_by_treatment_arm_and_overall_ITT_set_/24601648

الاتاحة: https://doi.org/10.1371/journal.pntd.0011780.t001
https://figshare.com/articles/dataset/Baseline_characteristics_by_treatment_arm_and_overall_ITT_set_/24601648